Spencer John
Transaction: 07/01/2026
OTHER
Change
0
Price
Not reported
Filing
07/07/2026
Type
OTHER
Oragenics, Inc.
OGEN • Biotechnology
$0.51
▲ +0.01 (+2.31%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.26M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 5.64Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:41 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.51
Change2.31%
Shares Out4.43M
Market Cap$2.26M
Enterprise Value$-1.61M
52W Range0.48 - 1.45
Beta1.24
P/E-0.22
P/B0.62
P/FCF-0.22
EV/EBITDA0.22
EV/FCF0.16
Price$0.51
Change2.31%
Shares Out4.43M
Market Cap$2.26M
Enterprise Value$-1.61M
52W Range0.48 - 1.45
Beta1.24
P/E-0.22
P/B0.62
P/FCF-0.22
EV/EBITDA0.22
EV/FCF0.16
Earnings Yield-446.45%
FCF Yield-451.94%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio5.64
Quick Ratio5.64
Volume4.70K
Avg Volume46.26K
EPS Surprise89.49
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 5.64Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
50/100
Neutral
Bullish
0
Hold
3
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Spencer John
Transaction: 07/01/2026
OTHER
Change
+10,000
Price
$0.93
Filing
07/07/2026
Type
OTHER
Telling Fred
Transaction: 12/12/2025
SELL
Change
-210
Price
$0.94
Filing
01/22/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Spencer John | OTHER | 0 | Not reported | 07/01/2026 | 07/07/2026 |
| Spencer John | OTHER | +10,000 | $0.93 | 07/01/2026 | 07/07/2026 |
| Telling Fred | SELL | -210 | $0.94 | 12/12/2025 | 01/22/2026 |
| Telling Fred | SELL | -210 | $0.94 | 12/12/2025 | 12/15/2025 |
| POPE CHARLES L | BUY | +125,000 | $0.93 | 12/11/2025 | 12/15/2025 |
| KOSKI ROBERT C | BUY | +125,000 | $0.93 | 12/11/2025 | 12/15/2025 |
| DUNTON ALAN W | BUY | +125,000 | $0.93 | 12/11/2025 | 12/15/2025 |
| GANDOLFO JOHN P | BUY | +125,000 | $0.93 | 12/11/2025 | 12/15/2025 |
| Telling Fred | BUY | +125,000 | $0.93 | 12/11/2025 | 12/15/2025 |
| Giordano Natasha | BUY | +38,320 | $1.03 | 12/11/2025 | 12/15/2025 |
| Huffman Janet | BUY | +250,000 | $0.93 | 12/11/2025 | 12/15/2025 |
| Giordano Natasha | OTHER | 0 | Not reported | 09/01/2025 | 09/02/2025 |
| Odyssey Health, Inc. | SELL | -5,044 | $4.26 | 06/18/2025 | 06/18/2025 |
| Odyssey Health, Inc. | SELL | -2,000 | $4.46 | 06/17/2025 | 06/18/2025 |
| Odyssey Health, Inc. | SELL | -5,000 | $4.45 | 06/16/2025 | 06/16/2025 |
| Odyssey Health, Inc. | SELL | -5,000 | $4.27 | 06/13/2025 | 06/16/2025 |
| Odyssey Health, Inc. | OTHER | 0 | Not reported | 12/28/2023 | 06/16/2025 |
| Odyssey Health, Inc. | OTHER | 0 | Not reported | 12/28/2023 | 06/16/2025 |
| KOSKI ROBERT C | SELL | -1,500,000 | Not reported | 12/11/2024 | 12/13/2024 |
| KOSKI ROBERT C | BUY | +5,000 | $0.50 | 12/11/2024 | 12/13/2024 |